Epidemiological and etiological characteristics of community-acquired pneumonia in conscripts in the modern period. Comparative evaluation of the effectiveness of pneumococcal vaccines

Epidemiological and etiological characteristics of community-acquired pneumonia in conscripts in the modern period. Comparative evaluation of the effectiveness of pneumococcal vaccines

The purpose of the study is to analyze morbidity and to determine etiology of community-acquired pneumonia of conscripts, to examine the epidemiological effectiveness of pneumococcal conjugate and non-conjugate polysaccharide vaccines for the prevention of community-acquired pneumonia in soldiers.Ma...

Full description

Bibliographic Details
Main Authors:	P. V. Kulikov, S. D. Zhogolev, R. M. Aminev, K. D. Zhogolev, A. A. Kuzin, S. R. Rubova, A. N. Gorenchuk, E. A. Mikheeva
Format:	Article
Language:	Russian
Published:	Journal Infectology 2019-05-01
Series:	Журнал инфектологии
Subjects:	внебольничные пневмонии военнослужащие по призыву заболеваемость этиология пцр-диагностика пневмококковая полисахаридная вакцина 23-валентная пневмококковая конъюгированная вакцина 13-валентная эффективность
Online Access:	https://journal.niidi.ru/jofin/article/view/891

Similar Items

Pharmacoeconomic aspects of vaccination against Pneumococcal Infection in Russia
by: A. V. Rudakova, et al.
Published: (2014-09-01)

PHARMACOECONOMIC ASSESSMENT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN IMMUNIZATION OF CHILDREN IN RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2014-01-01)

Immunization With a Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis Without Systemic Manifestations: a Prospective Study
by: Ekaterina I. Alexeeva, et al.
Published: (2018-01-01)

Modern approaches to the prevention of pneumococcal infection
by: S. M. Kharit, et al.
Published: (2015-12-01)

Experience of Vaccination of a Patient with Systemic Juvenile Idiopathic Arthritis (sJIA) with a 13-Valent Pneumococcal Conjugate Vaccine, prior to the Appointment of Therapy with Tocilizumab, an Anti-IL-6-Receptor Monoclonal Antibody
by: Daria D. Vankova, et al.
Published: (2018-10-01)

13-valent Pneumococcal Conjugate Vaccine and Haemophilus Influenzae-Tetanus Toxoid Conjugate Vaccine in Patient with Systemic Juvenile Idiopathic Arthritis Receiving Tocilizumab: Clinical Case
by: Ekaterina I. Alekseeva, et al.
Published: (2019-09-01)

Safety and efficacy of 23-valent polysaccharide pneumococcal vaccine in patients with systemic lupus erythematosus
by: G. M. Tarasova, et al.
Published: (2021-06-01)

The Effect of Different Regimens of Vaccination against Pneumococcal Infection on the Clinical Course of Chronic Obstructive Pulmonary Disease: Focus on Changes in Sputum Microorganism Population
by: M. P. Kostinov, et al.
Published: (2021-08-01)

THE EXPERIENCE OF PNEUMOCOCCAL CONJUGATE VACCINE USAGE IN ORPHANAGE INSTITUTION OF THE REPUBLIC OF MORDOVIA
by: A. A. Brovkina, et al.
Published: (2012-11-01)

Cost-effectiveness of vaccination against pneumococcal infection of adults at risk within the federal and regional programs
by: A. V. Rudakova, et al.
Published: (2019-12-01)

Vaccination against Pneumococcal Infections of High-Risk People: Pharmacoeconomic Aspects
by: A. V. Rudakova, et al.
Published: (2020-01-01)

The effectiveness of pneumococcal vaccination and dynamics of acute otitis media incidence in children
by: G. M. Letifov, et al.
Published: (2019-11-01)

EFFICACY OF PNEUMOCOCCAL INFECTIONS PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
by: E. V. Galkina-Lazareva
Published: (2012-05-01)

Clinical and Economic Efficiency of Vaccination in a Pneumococcal 13-Valent Conjugate Vaccine in Patients with Chronic Bronchitis at a Young Age
by: G. L. Ignatova, et al.
Published: (2017-04-01)

INFLUENZA VACCINATION OF CHILDREN OF PRESCHOOL AGE IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS OF QUADRIVALENT VACCINE
by: A. V. Rudakova, et al.
Published: (2019-03-01)

VACCINATION AGAINST PNEUMOCOCCAL INFECTIONS IN RUSSIAN FEDERATION: SOCIAL AND PHARMACOECONOMIC ASPECTS
by: A. V. Rudakova, et al.
Published: (2018-10-01)

Prevention of Pneumococcal Infection in Children with Chronic Diseases of the Nasopharynx Reduces the Incidence of Other Respiratory Tract Infections: Results of a Comparative Prospective Study
by: V. P. Vavilova, et al.
Published: (2015-11-01)

NASOPHARYNGEAL CARRIAGE OF STREPTOCOCCUS PNEUMONIAE IN ORPHANS, PRESCHOOL CHILDREN AND UNORGANIZED CHILDREN UNDER 5 YEARS
by: M. A. Lazareva, et al.
Published: (2015-04-01)

Cost-effectiveness of meningococcal vaccination of infants in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2021-12-01)

Immunogenicity and efficiency of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis: results of a 5-year follow up study
by: D. V. Bukhanova, et al.
Published: (2018-12-01)

Enhancing the National Vaccination Schedule in Russia
by: M. V. Fedoseenko
Published: (2015-12-01)

Efficacy of usage of pneumococcal 7-valent vaccine in prophylaxis of pneumococcal infection in Novosibirsk children from risk groups
by: O. A. Beletskaya, et al.
Published: (2013-03-01)

The effectiveness of immunization of children against Pneumococcal infection in Penza, Russia
by: O. N. Lesina, et al.
Published: (2019-04-01)

Immunological Efficacy and Safety of a New Pneumococcal Polysaccharide Conjugated Thirteen-Valent Vaccine in the Immunization of Adults and Children (Results of Clinical Studies in the Russian Federation)
by: I. V. Feldblium, et al.
Published: (2022-11-01)

Factors that Influence the Coverage of Vaccination against Pneumococcal Infections of Children up to 1 Year Old of Age at the Starting Phase of Vaccination
by: N. N. Filatov, et al.
Published: (2017-06-01)

New Arguments in favor of the Release Active Antiviral Drug to Prepare Children for Vaccination
by: V. P. Vavilova, et al.
Published: (2015-12-01)

Assessment of Safety, Immunogenicity and Preventive Efficacy of Prevenar-13 in Children with Bronchopulmonary Dysplasia
by: E. S. Zubova, et al.
Published: (2018-04-01)

Vaccination as a solution of the issue of resistance S. pneumoniae
by: H. P. Ruban, et al.
Published: (2021-05-01)

Experience in Immunizing HIV-Infected Children against Pneumococcal Infection and Influenza
by: O. I. Nazarova, et al.
Published: (2020-09-01)

Vaccination in Patients with Chronic Lymphocytic Leukemia: Current Problems
by: M. I. Kislova, et al.
Published: (2021-07-01)

Epidemiological parallels of community-acquired pneumonia, influenza and ARVI in Moscow
by: T. S. Saltykova, et al.
Published: (2020-04-01)

Efficacy and Safety of Immunization With Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis: Preliminary Results of a Prospective Open-Label Study
by: Ekaterina I. Alexeeva, et al.
Published: (2017-06-01)

Immunization Str.pneumonia vaccine reduces the incidence orphanage children’s acute otitis media (preliminary results)
by: A. A. Dzhumagaziev, et al.
Published: (2014-09-01)

The Experience of a Comparative Analysis of the Incidence of Pneumonia and Acute Respiratory Infections of the Upper Respiratory Tract after the Introduction of a System of Epidemiological Monitoring of Pneumonia
by: N. A. Kravchenko, et al.
Published: (2019-03-01)

The impact of vaccination against influenza and pneumococcal infection on the incidence of acute respiratory viral infections and community-acquired pneumonia in the Central Administrative District of Moscow
by: O. A. Gruzdeva, et al.
Published: (2021-05-01)

The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Rheumatoid Arthritis
by: M. S. Naumtseva, et al.
Published: (2015-08-01)

MULTILOCI SEQUESTERANT STRAINS OF STREPTOCOCCUS PNEUMONIAE ISOLATED FROM ELDERLY PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
by: A. V. Martynova, et al.
Published: (2014-06-01)

Observational Safety Study of Meningococcal Conjugate Vaccine Against Serogroups A, C, W and Y (Menactra) Used in Routine Healthcare Practice for Persons Aged 2 to 55 Years in Russian Federation
by: I. Ya. Izvekova, et al.
Published: (2019-01-01)

Efficacy of Pneumococcal Polysaccharide Conjugate Vaccine (13-valent, Adsorbed) in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Genetically Engineered Biologic Drugs (Tocilizumab or Canakinumab): Prospective Cohort Study
by: Ekaterina I. Alexeeva, et al.
Published: (2020-08-01)

EXPERIENCE OF USING IMMUNE CHROMATOGRAPHY TEST FOR DIAGNOSTICS OF PNEUMOCOCCAL PNEUMONIA
by: V. V Nikolenko, et al.
Published: (2015-06-01)